To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1745 | Desmethyl Mk-6884 |
Precursor for PET imaging 11C-radiolabeled MK-6884
More description
|
|
| DCC1744 | Desfluoro Ezetimibe |
Desfluoro impurity of Ezetimibe
More description
|
|
| DCC1743 | Deramciclane Fumarate |
Inhibitor of acetyl-CoA carboxylase (ACC), activating GPR40, inhibiting West Nile virus (WNV) infection and reducing the multiplication of Usutu virus (USUV), a WNV-related flavivirus
More description
|
|
| DCC1742 | Dequalinium Bromide |
HIV-1 fusion inhibitor, targeting the membrane-proximal external region of Env spikes, specifically inhibiting the HIV-1 envelope-mediated membrane fusion by blocking CD4-induced conformational changes
More description
|
|
| DCC1741 | Depmpo |
Most efficient spin trap for the in vitro and in vivo detection of O-, N-, S- and C-centered free radicals
More description
|
|
| DCC1740 | Deoxynybomycin |
Selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I
More description
|
|
| DCC1739 | Deoxy-dalsir |
Novel selective and sensitive near-infrared fluorescent probe for visualization of endogenous nitric oxide in living cells and animals
More description
|
|
| DCC1738 | Deox B 7,4 |
Novel reversible microtubule inhibitor, increasing lysosomal V-ATPase activity and lysosome acidity
More description
|
|
| DCC1737 | Denv2-in-3 |
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
|
|
| DCC1736 | Denv2-in-2 |
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
|
|
| DCC1735 | Denv2-in-1 |
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
|
|
| DCC1734 | Denosomin |
Novel anti-Alzheimer's disease agent, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin
More description
|
|
| DCC1733 | Denaverine Hydrochloride |
Antispasmodic agent, improving the elasticity of the soft birth canal and regulating labor contractions
More description
|
|
| DCC1732 | Denagliptin Tosylate |
Selective DPP-IV Inhibitor
More description
|
|
| DCC1731 | Demethoxyviridin |
Potent inhibitor of PI3 kinases
More description
|
|
| DCC1730 | Delta-tocopherol |
Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades
More description
|
|
| DCC1729 | Delcasertib |
Novel selective δ-protein kinase C inhibitor
More description
|
|
| DCC1728 | Dehydrorabelomycin |
Natural polyketide matabolite
More description
|
|
| DCC1727 | Degrader Bt1 |
Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells
More description
|
|
| DCC1726 | Deferoxamine Hydrochloride |
Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile
More description
|
|
| DCC1725 | Deferasirox Ferrate(iii) Tripotassium Complex |
Deferasirox iron complex
More description
|
|
| DCC1724 | Debio-1452-nh3 |
Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli
More description
|
|
| DCC1723 | Deac-pda-atp |
Fluorophore to myosin or actomyosin
More description
|
|
| DCC1722 | Deacm-caged D-luciferin |
Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm
More description
|
|
| DCC1721 | Dea Nonoate Sodium Salt |
NO donor, generating a controlled release of nitric oxide in solution.
More description
|
|
| DCC1720 | Ddr-trk-1n |
Negative control for DDR-TRK-1
More description
|
|
| DCC1719 | Ddri-18 |
Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin
More description
|
|
| DCC1718 | Ddr1-in-2 |
Potent and selective DDR1 receptor tyrosine kinase inhibitor
More description
|
|
| DCC1717 | ddpm-1457 |
Potent mGAT4 inhibitor
More description
|
|
| DCC1716 | Ddo-7204 |
Novel Nrf2 activator
More description
|
|